Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligenceSilver IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligenceSilver IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
LOOK INSIDE THE BUSINESS

Company financials.

Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.

View DERM insider activity ↗

DERMJourney Medical Corp

THE LATEST REPORTED YEAR

The company reported a loss.

$11.43M net loss for the year ended December 31, 2025. These are reported results, not a forecast or a stock recommendation.

Revenue$61.24MYear ended December 31, 2025
Profit or loss-$11.43MYear ended December 31, 2025
Cash from the business-$12.44MYear ended December 31, 2025
Total assets$98.36MAs of June 30, 2026
Total liabilities$66.24MAs of June 30, 2026
Cash & equivalents$25.64MAs of June 30, 2026
THE BUSINESS BEHIND THE TICKER

Revenue, over time.

Latest-filed standard financial facts · USD

$44.53M
2020-12
$63.13M
2021-12
$71M
2022-12
$59.66M
2023-12
$55.13M
2024-12
$61.24M
2025-12

Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.

From the filing

Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.

Reported periodReported valueFiledSource
January 1, 2025 – December 31, 2025$61,239,000March 26, 202610-K ↗
January 1, 2024 – December 31, 2024$55,134,000March 26, 202610-K ↗
January 1, 2023 – December 31, 2023$59,662,000March 27, 202510-K ↗
January 1, 2022 – December 31, 2022$70,995,000March 29, 202410-K ↗
January 1, 2021 – December 31, 2021$63,134,000March 31, 202310-K ↗
January 1, 2020 – December 31, 2020$44,531,000March 28, 202210-K ↗
Source and calculation details

One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.

Concept: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · Retrieved October 11, 2026

Response SHA-256: f7120f93e3775e58a003508c511d3ada0a8cbf31946c6601b0fd76e1e864a01d

SEC company facts

Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.